glp 1 development history The expanding landscape of GLP-1 medicines Glucagon-like peptide-1 receptor: mechanisms and

Incretin based therapies, such as glucagon-like peptide-1 (GLP-1) receptor agonists mimic the hormone that originates from the small intestine and is released in response to nutrition intake

Two symbols (**, ##, or $$) denote significant difference below 0.005, three symbols (***, ###, or $$$) denote significant below 0.0001

In addition, the SUMMIT trial evaluates the effect of tirzepatide (the GLP-1/GIP dual receptor agonist) in people with obesity-related HFpEF (Clinicaltrials.gov ID NCT04847557)

Semaglutide is FDA-approved in the form of injections (Ozempic, Wegovy) or oral tablets (Rybelsus)

2026-02-13

Your total household income must be at or below 400% of the Federal Poverty Level (FPL)